June 2, 2026 · Form 4 insider transaction
BALL KRISTINE M bought 9,136 shares of Oruka Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The option vests as to 1/12 of the underlying shares monthly from June 2, 2026.